Top

International Urogynecology Journal

Published in:

01-07-2018 | Original Article

Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome

Authors: Ming-Huei Lee, Kun-Min Chang, Wen-Chen Tsai

Published in: International Urogynecology Journal | Issue 7/2018

Abstract

Introduction and hypothesis

The objective was to calculate the morbidity rate and medical utilization of interstitial cystitis/painful bladder syndrome (IC/PBS) over 12 years using a nationwide database of Taiwan.

Methods

This was a cohort study of the Longitudinal Health Insurance Database 2010 with new diagnoses of IC/PBS from 2002 through 2013. The morbidity rate was adjusted for age, sex, and calendar date using density methods. Moreover, medical utilization during the study period was measured.

Results

It was observed that the incidence of IC/PBS was 21.8/100,000 in 2002 and 21.1/100,000 in 2013. The prevalence of IC/PBS was 21.8/100,000 in 2002 and 40.2/100,000 in 2013. In 2003, the incidence and prevalence of women was 28.6/100,000 and 63.5/100,000 respectively. The incidence and prevalence of men was 12.3/100,000 and 19.4/100,000 respectively. In 2002, the incidence was 45.5/100,000, 32.4/100,000, and 9/100,000 in the age groups above 65, 40–65, and under 40 years respectively. The prevalence in 2003 was 86.3/100,000, 63.1/100,000, and 16.4/100,000 in age groups above 65, 40–65, and under 40 years respectively. This pattern was similar until 2013. The mean outpatient and inpatient visit time was 4.8 and 1.8 times per year respectively. The mean surgical fee (US$ 246.6 ± 304.5) was 23.6% of the total fee.

Conclusions

The morbidity rate of IC/PBS showed a higher incidence and prevalence in women and older patients. A new drug for the treatment of IC/PBS may be a factor of the peak in the morbidity rate. The increase in medical utilization could be explained by the awareness of physicians and patients seeking medical help.

Available only for authorised users

Hanno P, Levin RM, Monson FC, Teuscher C, Zhou ZZ, Ruggieri M, et al. Diagnosis of interstitial cystitis. J Urol. 1990;143(2):278–81.

Van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7. https://doi.org/10.1016/j.eururo.2007.09.019.

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–78.

Leppilahti M, Tammela TLJ, Huhtala H, Auvinen A. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol. 2002;168(1):139–43. https://doi.org/10.1016/S0022-5347(05)64847-1.CrossRefPubMed

Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999;161(2):549–52. https://doi.org/10.1016/S0022-5347(01)61947-5.CrossRefPubMed

Oravisto KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn. 1975;64(2):75–7.PubMed

Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173(1):98–102; discussion 102. https://doi.org/10.1097/01.ju.0000146114.53828.82.CrossRefPubMed

Roberts RO, Bergstralh EJ, Bass SE, Lightner DJ, Lieber MM, Jacobsen SJ. Incidence of physician-diagnosed interstitial cystitis in Olmsted County: a community-based study. BJU Int. 2003;91(3):181–5.CrossRefPubMed

Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases workshop on interstitial cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol. 1988;140(1):203–6.CrossRefPubMed

10.

Kusek JW, Nyberg LM. The epidemiology of interstitial cystitis: is it time to expand our definition? Urology. 2001;57(6 Suppl 1):95–9.CrossRefPubMed

11.

Held PJHP, Wein AJ, Pauly MV, Cann MA. Interstitial cystitis. Epidemiology of interstitial cystitis. 1st ed. New York: Springer; 1990. https://doi.org/10.1007/978-1-4471-3293-6.CrossRef

12.

Lee M-H. Report from interstitial cystitis/painful bladder syndrome committee. Incont Pelvic Floor Dysfunct. 2009;3(4):119–22.

13.

Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70. https://doi.org/10.1016/j.juro.2011.03.064.

14.

Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA. 2012;308(18):1906–14.

15.

Lifford KL, Curhan GC. Prevalence of painful bladder syndrome in older women. Urology. 2009;73(3):494–8. https://doi.org/10.1016/j.urology.2008.01.053.CrossRefPubMed

16.

Parsons JK, Kurth K, Sant GR. Epidemiologic issues in interstitial cystitis. Urology. 2007;69(4 Suppl):5–8. https://doi.org/10.1016/j.urology.2006.05.050.CrossRefPubMed

17.

Parsons CL. Interstitial cystitis: a chronic disease with ever-increasing recognition and prevalence. J Urol. 2005;173(1):6. https://doi.org/10.1097/01.ju.0000148569.76480.bd.CrossRefPubMed

18.

Parsons CL, Dell J, Stanford EJ, Bullen M, Kahn BS, Willems JJ. The prevalence of interstitial cystitis in gynecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obstet Gynecol. 2002;187(5):1395–400.CrossRefPubMed

19.

Parsons CL, Dell J, Stanford EJ, Bullen M, Kahn BS, Waxell T, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60(4):573–8.

20.

Rothman KJ (2012) Epidemiology: an introduction. New York: Oxford University Press.

21.

Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189(1):141–5. https://doi.org/10.1016/j.juro.2012.08.088.CrossRefPubMed

22.

Cox A, Golda N, Nadeau G, Curtis Nickel J, Carr L, Corcos J, et al. CUA guideline: diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10(5-6):E136–E155. https://doi.org/10.5489/cuaj.3786.

23.

Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–53. https://doi.org/10.1016/j.juro.2015.01.086.CrossRefPubMed

24.

Wu EQ, Birnbaum H, Mareva M, Parece A, Huang Z, Mallett D, et al. Interstitial cystitis: cost, treatment and co-morbidities in an employed population. Pharmacoeconomics. 2006;24(1):55–65.

25.

Clemens JQ, Meenan RT, Rosetti MC, Kimes T, Calhoun EA. Costs of interstitial cystitis in a managed care population. Urology. 2008;71(5):776–80; discussion 780–1. https://doi.org/10.1016/j.urology.2007.11.154.

26.

Tung A, Hepp Z, Bansal A, Devine EB. Characterizing health care utilization, direct costs, and comorbidities associated with interstitial cystitis: a retrospective claims analysis. J Manag Care Spec Pharm. 2017;23(4):474–82. https://doi.org/10.18553/jmcp.2017.23.4.474.CrossRefPubMed

27.

Nickel JC. Opioids for chronic prostatitis and interstitial cystitis: lessons learned from the 11th World Congress on Pain. Urology. 2006;68(4):697–701. https://doi.org/10.1016/j.urology.2006.04.013.CrossRefPubMed

28.

Burkman RT. Chronic pelvic pain of bladder origin: epidemiology, pathogenesis and quality of life. J Reprod Med. 2004;49(3 Suppl):225–9.PubMed

29.

Lee M-H, Lin AT-L, Kuo H-C, Chen Y-F. Clinical characteristic picture and impact of symptoms on quality of life of interstitial cystitis patients in Taiwan. Low Urin Tract Symptoms. 2014;6(1):20–5. https://doi.org/10.1111/luts.12013.CrossRefPubMed

Title: Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome
Authors: Ming-Huei Lee
Kun-Min Chang
Wen-Chen Tsai
Publication date: 01-07-2018
Publisher: Springer London
Published in: International Urogynecology Journal / Issue 7/2018
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-018-3574-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2018

Effects of urine alkalinization with sodium bicarbonate orally on lower urinary tract symptoms in female patients: a pilot study

Commentary on: Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder

Ergonomics: making the OR a comfortable place

Commentary on “Comparison of adjustable continence therapy periurethral balloons and artificial urinary sphincter in female patients with stress urinary incontinence due to intrinsic sphincter deficiency”

Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder

Recalcitrant chronic bladder pain and recurrent cystitis but negative urinalysis: What should we do?